Skip to main content
All Posts By


The Barcelona Science Park is committed to becoming Catalonia’s MedTech company hub

The Barcelona Science Park (PCB), a Spain’s leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 square metres of office space, particularly to companies in the MedTech sector. To promote this ecosystem, it has signed an alliance with GENESIS Biomed. This consultancy firm, based in PCB, has raised more than 60 million euros for its clients since it was founded in May 2017 by Josep Lluis Falcó.


Read More

A pioneering study conducted by Eugin reveals that women with Covid-19 produce virus-free eggs

A study carried out by a team of researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park, published in the  journal Human Reproduction, has, for the first time, analysed the eggs of women diagnosed with Covid-19 detecting no viral material within them. The findings, globally considered ground-breaking and pioneering in the field of assisted reproduction, supports the notion that there would be no vertical transmission of the infection from mother to child via their eggs.


Read More

Oncoheroes receives from FDA the Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma

Oncoheroes Bioscience –a Boston based biotech with the European subsidiary at the Barcelona Science Park– focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to volasertib, an investigational treatment for rhabdomyosarcoma.


Read More

New findings on the function of Mitofusin 2 in bacterial infection and inflammation processes

A study published in the journal Cell Reports describes new functions of the protein Mitofusin 2 (Mfn2) in macrophages –cells that take part in the defensive and inflammatory response– under immunological stress conditions. The article sheds light on the expression mechanisms of proinflammatory cytokines, molecules that can appear uncontrolledly –known as the cytokine storm– over the course of bacterial and viral infections.


Read More

The CNAG-CRG participates in a European project to improve medical assistance through interceptive medicine

Scientists from the Centro Nacional de Análisis Genómico (CNAG-CRG), based in Barcelona Science Park and integrated to the Centre for Genomic Regulation (CRG) unites with hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united to revolutionize healthcare on the frame of LifeTime initiative. They are participating in two publications: a perspective article in the journal Nature and the LifeTime Strategic Research Agenda. They are now presenting how to improve leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.


Read More

IBEC and IRB Barcelona researchers receive funding from “La Caixa” for biomedical research

Researchers from the Institute of Bioengineering of Catalonia (IBEC) and the Barcelona Institute for Biomedical Research (IRB) -based in the Barcelona Science Park- are part of the winning projects of the third Call for Applications Health Research Projects organized by “La Caixa ” Foundation, which this year allocates 18 million euros to 25 biomedical projects to tackle those diseases with the greatest global impact, such as cardiovascular, neurological, infectious and oncological.

Read More